Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player

M Wesseling, JHC de Poel, SCA de Jager - ESC Heart Failure, 2020 - Wiley Online Library
Heart failure is a growing health issue as a negative consequence of improved survival
upon myocardial infarction, unhealthy lifestyle, and the ageing of our population. The large …

Growth differentiation factor 15 in heart failure: an update

KC Wollert, T Kempf - Current heart failure reports, 2012 - Springer
Abstract Growth differentiation factor 15 (GDF-15) is a stress-responsive cytokine expressed
in the cardiovascular system. GDF-15 is emerging as a biomarker of cardiometabolic risk …

GDF 15-a novel biomarker in the offing for heart failure

M George, A Jena, V Srivatsan… - Current cardiology …, 2016 - ingentaconnect.com
Background: Several diagnostic and prognostic biomarkers are being explored in heart
failure. GDF-15 belongs to the transforming growth factor β (TGF-β) cytokine family that is …

Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside

X Xu, Z Li, W Gao - Biomarkers, 2011 - Taylor & Francis
Context: Growth differentiation factor 15 (GDF-15) is a novel cytokine showing close
association with cardiovascular diseases. The biological mechanism and clinical use of GDF …

Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial

IS Anand, T Kempf, TS Rector, H Tapken, T Allhoff… - Circulation, 2010 - Am Heart Assoc
Background—Growth-differentiation factor-15 (GDF-15) is emerging as a prognostic
biomarker in patients with coronary artery disease. Little is known about GDF-15 as a …

[HTML][HTML] The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction

R Stahrenberg, F Edelmann, M Mende… - European journal of …, 2010 - Wiley Online Library
Aims Heart failure with normal ejection fraction (HFnEF) is an important clinical entity that
remains incompletely understood. The novel biomarker growth differentiation factor 15 (GDF …

Growth differentiation factor 11: A new hope for the treatment of cardiovascular diseases

Y Shao, Y Wang, J Xu, Y Yuan, D Xing - Cytokine & Growth Factor Reviews, 2023 - Elsevier
ABSTRACT Growth differentiation factor 11 (GDF11) is a member of the transforming growth
factor-β superfamily that has garnered significant attention due to its anti-cardiac aging …

[HTML][HTML] Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases

AM di Candia, DX de Avila, GR Moreira… - American Heart Journal …, 2021 - Elsevier
Abstract Growth differentiation factor-15 (GDF-15) is a cytokine upregulated in multiple
pathological conditions where oxidative stress, endothelial dysfunction, tissue aging, and …

Growth differentiation factor-15: a new biomarker in cardiovascular disease

T Kempf, KC Wollert - Herz, 2009 - search.proquest.com
Abstract Growth differentiation factor-(GDF-) 15 is a stress-responsive cytokine that is
emerging as a biomarker of cardiac and vascular dysfunction and disease. Elevated …

[HTML][HTML] A meta-analysis of growth differentiation factor-15 and prognosis in chronic heart failure

JW Luo, WH Duan, L Song, YQ Yu… - Frontiers in cardiovascular …, 2021 - frontiersin.org
Background: Previous studies had reported increased circulating concentrations of growth
differentiation factor-15 (GDF-15) in chronic heart failure (CHF), suggesting the potential …